St Louis, MISSOURI5 Active Studies

Multiple Sclerosis Clinical Trials in St Louis, MISSOURI

Find 5 actively recruiting multiple sclerosis clinical trials in St Louis, MISSOURI. Connect with local research sites and explore new treatment options.

5
Active Trials
4
Sponsors
795
Enrolling

Recruiting Multiple Sclerosis Studies in St Louis

RecruitingSt Louis, MISSOURINCT06220669

A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis

The main purpose of this study is to evaluate the safety and efficacy of LY3541860 in adult participants with multiple sclerosis that gets worse and gets better. The study will last about 9 months wit...

200 participants
Eli Lilly and Company
View Study Details
RecruitingSt Louis, MISSOURINCT06782490

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986368 in participants with Multiple Sclerosis Spasticity...

200 participants
Celgene
View Study Details
RecruitingSt Louis, MISSOURINCT06408259

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

The purpose of this study is to evaluate the effectiveness, safety, tolerability, drug levels and drug effects of ozanimod compared to fingolimod in children and adolescents with relapsing remitting m...

194 participants
Celgene
View Study Details
RecruitingSt Louis, MISSOURINCT04047628

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hematopoietic Stem Cell Transplantation (AHSCT...

156 participants
National Institute of Allergy and Infectious Diseases (NIAID)
View Study Details
RecruitingSt Louis, MISSOURINCT05985161

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

The purpose of this study is to find out whether selinexor is an effective treatment for people who have a relapsed/refractory Wilms tumor, rhabdoid tumor, MPNST, or another solid tumor that makes a h...

45 participants
Memorial Sloan Kettering Cancer Center
View Study Details

About Multiple Sclerosis Clinical Trials in St Louis

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 5 multiple sclerosis clinical trials recruiting participants in St Louis, MISSOURI. These studies are seeking a combined 795 participants. Research is being sponsored by Eli Lilly and Company, Celgene, National Institute of Allergy and Infectious Diseases (NIAID) and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in St Louis — FAQ

Are there multiple sclerosis clinical trials in St Louis?

Yes, there are 5 multiple sclerosis clinical trials currently recruiting in St Louis, MISSOURI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in St Louis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the St Louis research site will contact you about next steps.

Are clinical trials in St Louis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many St Louis studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 5 active trials in St Louis are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated March 2, 2026 from ClinicalTrials.gov